title: Homocysteine--should we screen and treat in preventive cardiology programs?
authors.affiliation: Department of Clinical Haematology, Monash Medical Centre, Clayton, Victoria.
authors.forename: Huyen
authors.initials: H
authors.lastname: Tran
authors.forename: Graeme J
authors.initials: GJ
authors.lastname: Hankey
authors.forename: John W
authors.initials: JW
authors.lastname: Eikelboom
mesh_terms: D002318:Cardiovascular Diseases / Q000097:blood* / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D006711:Homocystine / Q000097:blood* / Q000378:metabolism; D006801:Humans; D020138:Hyperhomocysteinemia / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D008403:Mass Screening; D011322:Primary Prevention; D014481:United States / Q000453:epidemiology; D014803:Vitamin B Complex / Q000627:therapeutic use
chemical_list: D014803:Vitamin B Complex; D006711:Homocystine